Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
University of Arizona
University of Arizona
Shenzhen TargetRx, Inc.
American Regent, Inc.
Novartis
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center
Karyopharm Therapeutics Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Xencor, Inc.
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Novartis
Novartis
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Bio-Path Holdings, Inc.
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Novartis
Masonic Cancer Center, University of Minnesota
Arbeitsgemeinschaft medikamentoese Tumortherapie
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Takeda
Traws Pharma, Inc.
Masonic Cancer Center, University of Minnesota
AbbVie
National Institutes of Health Clinical Center (CC)
UConn Health
M.D. Anderson Cancer Center
Sunesis Pharmaceuticals
Prescient Therapeutics, Ltd.
Novartis
Virginia Commonwealth University
Novartis
Novartis
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
University Health Network, Toronto
Otsuka Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
M.D. Anderson Cancer Center
Threshold Pharmaceuticals
Novartis
National Cancer Institute (NCI)